Search Results

Business

Arbor Biosciences and LGC, Biosearch Technologies Partner on Marker Discovery and Genotyping in Agrigenomics

Arbor Biosciences announced a partnership with Biosearch Technologies, the complete genomics portfolio of LGC Group.

January 30, 2020

·

3 min read

OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies to Accelerate Production of Asymmetric siRNA for the Treatment of Sub-Retinal Fibrosis and Wet Macular Degeneration

OliX Pharmaceuticals, Inc. announced that the Company signed an exclusive contract with LGC Biosearch Technologies Inc., a contract development and manufacturing organization and part of the global life sciences tools company headquartered in London, to scale production of OliX’s OLX301D therapeutic candidate.

June 16, 2020

·

3 min read

LGC’s ValuPanel Reagents help public laboratories detect SARS-CoV-2 and influenza

LGC, Biosearch Technologies today announces the release of a new set of ValuPanel™ Reagents to help the efforts of public health laboratories to detect SARS-CoV-2, influenza A, and influenza B.

February 2, 2021

·

3 min read

Novel enzyme from LGC, Biosearch Technologies is fast and specific, even at room temperature

LGC, Biosearch Technologies proudly introduces RapiDxFire™ Thermostable RT, a truly thermostable reverse transcriptase designed specifically to meet the needs of diagnostic kit developers.

March 8, 2019

·

2 min read

OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies to Accelerate Production of Asymmetric siRNA for the Treatment of Androgenic Alopecia

OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), announced that the companies signed an exclusive contract to scale production of OliX’s OLX104C, an investigational RNAi therapeutic in development for the treatment of androgenic alopecia.

June 9, 2021

·

3 min read

Business

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

October 24, 2018

·

3 min read

Deals

U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business

Alliance Pharma, a U.S. leader in small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry, closed on the purchase of Drug Development Solutions, a U.K.-based bioanalytical and material science testing contract research organization, from LGC.

July 13, 2022

·

4 min read

Press Releases

FBB Biomed Signs Agreement with Verici Dx plc to Offer Research-Use-Only “RUO” Tests to Clinicians

December 2, 2024

·

2 min read

Business

Swift Biosciences and LGC Partner on Targeted Sequencing Assays for AgBio Market

ANN ARBOR, Mich. , Feb. 24, 2020 /PRNewswire/ -- Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), today announced a partnership agreement with LGC, Biosearch Technologies, a global leader in specialty genomic analysis tools to leverage Swift’s targeted sequencing technology into LGC Biosearch T

February 24, 2020

·

4 min read

Deals

Ampersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder

Alliance Pharma, a US-based Bioanalytical CRO and an Ampersand portfolio company, has agreed to acquire DDS, a UK-based Bioanalytical Business Unit of LGC.

May 17, 2022

·

5 min read